quinacrine has been researched along with Graft-Versus-Host Disease in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeKlerk, JN | 1 |
| Murphy, GP | 1 |
| Van Zyl, JJ | 1 |
| Van Zyl, JA | 1 |
| Weber, HW | 1 |
| Brede, HD | 1 |
| Scott, WW | 1 |
1 other study available for quinacrine and Graft-Versus-Host Disease
| Article | Year |
|---|---|
New methods of treatment for renal allotransplants using the baboon as a primate experimental model.
Topics: Animals; Antibodies; Azathioprine; Cyclophosphamide; Female; Globulins; Graft vs Host Disease; Haplo | 1969 |